Production of recombinant proteins generates a variety of process-related impurities. The multistep manufacturing processes may introduce many potential contaminants into the final pharmaceutical products. These residual impurities and contaminants can potentially impact the protein stability significantly. In this short review, the authors intend to discuss major sources and types of residual process-related impurities and potential product contaminants, their impact on protein quality/stability, and possible mitigations during product development and manufacturing processes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jps.23931 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!